Ruiang Gene: It is expected that the annual net profit will be a loss of 39.90 million to 59.86 million yuan in 2025.

Ruiong Genes announcement: it is expected that the net profit attributable to the owner of the parent company will be in a loss in the annual report of 2025, with a range of -39.9069 million to -59.8603 million. During the reporting period, influenced by the medical industry environment, downstream customers' payments have slowed down, and the company has increased the provision for credit impairment losses on accounts receivable in accordance with the bad debt policy.